Bart S. Hendriks
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in ⓘ
- Oncology 35
- HER2/EGFR in Cancer Research 18
- Lung Cancer Research Studies 7
- Cancer Treatment and Pharmacology 6
-
- Monoclonal and Polyclonal Antibodies Research 18
- Radiopharmaceutical Chemistry and Applications 13
- Co-authors
- Douglas A. Lauffenburger (12 shared papers)H Wiley (4 shared papers)Thomas J. Wickham (19 shared papers)Elena Geretti (16 shared papers)Lee K. Opresko (2 shared papers)Shannon C. Leonard (13 shared papers)Helen Lee (17 shared papers)Daniel F. Gaddy (13 shared papers)
- Journals
- Cancer Research (13 papers)Molecular Cancer Therapeutics (4 papers)British Journal of Cancer (3 papers)Clinical Cancer Research (2 papers)Theranostics (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Bart S. Hendriks
62 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 122
- Biomaterials 706
- Oncology 785
- Radiology, Nuclear Medicine and Imaging 580
- Molecular Biology 1.1k
- Biomedical Engineering 610
Countries citing papers authored by Bart S. Hendriks
This map shows the geographic impact of Bart S. Hendriks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart S. Hendriks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart S. Hendriks more than expected).
Fields of papers citing papers by Bart S. Hendriks
This network shows the impact of papers produced by Bart S. Hendriks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart S. Hendriks. The network helps show where Bart S. Hendriks may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart S. Hendriks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 285 | |
| 2 | 2003 | 153 | |
| 3 | 2017 | 134 | |
| 4 | Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects. | 2003 | 114 |
| 5 | 2009 | 109 | |
| 6 | 2016 | 96 | |
| 7 | 2018 | 95 | |
| 8 | 2012 | 93 | |
| 9 | 2006 | 91 | |
| 10 | 2021 | 88 | |
| 11 | 2008 | 75 | |
| 12 | 2013 | 72 | |
| 13 | 2004 | 61 | |
| 14 | 2021 | 56 | |
| 15 | 2018 | 54 | |
| 16 | 2012 | 54 | |
| 17 | 2003 | 52 | |
| 18 | 2015 | 51 | |
| 19 | 2013 | 50 | |
| 20 | 2018 | 50 |
About Bart S. Hendriks
Bart S. Hendriks is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Biomaterials, Pharmacology and Molecular Biology, having authored 64 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Nanoparticle-Based Drug Delivery (13 papers), Radiopharmaceutical Chemistry and Applications (13 papers), Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (7 papers), Cancer Treatment and Pharmacology (6 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Biomaterials (706 citations), Oncology (785 citations), Radiology, Nuclear Medicine and Imaging (580 citations), Molecular Biology (1.1k citations) and Biomedical Engineering (610 citations). Bart S. Hendriks has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Douglas A. Lauffenburger, H Wiley, Thomas J. Wickham, Elena Geretti, Lee K. Opresko, Shannon C. Leonard, Helen Lee, Daniel F. Gaddy, Christopher W. Espelin and David de Graaf. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, British Journal of Cancer, Clinical Cancer Research and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.